Загрузка...
Combination therapy for scalp angiosarcoma using bevacizumab and chemotherapy: a case report and review of literature
Bevacizumab, an angiogenesis inhibitor, is a recombined humanized monoclonal antibody against vascular endothelial growth factor and a promising therapeutic option for angiosarcoma management. This is a case report and review of the literature using bevacizumab and combination chemotherapy for angio...
Сохранить в:
| Главные авторы: | , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
AME Publishing Company
2013
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3696716/ https://ncbi.nlm.nih.gov/pubmed/23825914 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3978/j.issn.1000-9604.2013.06.09 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|